Lotus Pharmaceutical Co., Ltd. (TPE:1795)
187.00
+1.00 (0.54%)
Sep 12, 2025, 1:30 PM CST
Lotus Pharmaceutical Revenue
Lotus Pharmaceutical had revenue of 4.75B TWD in the quarter ending June 30, 2025, with 0.09% growth. This brings the company's revenue in the last twelve months to 19.12B, up 12.91% year-over-year. In the year 2024, Lotus Pharmaceutical had annual revenue of 18.58B with 9.59% growth.
Revenue (ttm)
19.12B
Revenue Growth
+12.91%
P/S Ratio
2.57
Revenue / Employee
17.40M
Employees
1,099
Market Cap
49.18B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 18.58B | 1.63B | 9.59% |
Dec 31, 2023 | 16.96B | 2.33B | 15.89% |
Dec 31, 2022 | 14.63B | 1.98B | 15.68% |
Dec 31, 2021 | 12.65B | 1.92B | 17.90% |
Dec 31, 2020 | 10.73B | 1.12B | 11.63% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Caliway Biopharmaceuticals | 44.83M |
PharmaEssentia | 12.63B |
Bora Pharmaceuticals Co., LTD. | 21.32B |
Lumosa Therapeutics | 37.25M |
Oneness Biotech | 112.57M |
Polaris Group | 64.02M |
Center Laboratories | 1.60B |
Pell Bio-Med Technology | 27.43M |